Meloxicam is an enolcarboxamide with preferential COX-2 activity. Studies conducted on experimental models and human tissues indicate that meloxicam is a more potent inhibitor of COX-2 than COX-1 ...
An interleukin-1β-mediated induction of COX-2 in the central nervous system contributes to inflammatory pain hypersensitivity. Nature 410 , 471–475 (2001). Article CAS Google Scholar ...
Meloxicam reaches maximum plasma concentration (Cmax) at 9-11 hours after a 30mg dose and 2.5-7 hours after a 15mg dose. Meloxicam is strongly bound to plasma proteins (99.5%). Meloxicam displays ...
COX-2 selective inhibitors belong to the family of nonsteroidal anti-inflammatory drugs (NSAIDs). NSAIDs reduce pain, fever and inflammation, but many can also lead to gastric bleeding ...
NSAIDs-- or nonsteroidal anti-inflammatory drugs -- are among the ... They block the effects of special enzymes -- specifically Cox-1 and Cox-2 enzymes. These enzymes play a key role in making ...
The development of safer and more effective anti-inflammatory drugs also presents vibrant opportunities. However, the market faces substantial challenges, such as stringent regulatory policies and the ...
Hunnes says that betalain has anti-inflammatory properties because it can suppress the cyclooxygenase-2 (COX-2) enzyme which is associated with inflammation. Chronic inflammation can cause damage ...